作为一项孕前/孕早期筛查技术,携带者筛查已经由最初仅针对特定人群、特定疾病发展为现如今的针对一般人群、多种疾病的筛查,在防控常染色体隐性或X连锁遗传病引起的出生缺陷方面表现出了显著的临床效用,增加了受检夫妇的生育自主权。为规范携带者筛查的实验室检测和临床实施,经中国妇幼保健协会生育保健分会专家讨论,结合我国实际情况,制定本专家共识,供临床应用参考。
As a pre-pregnancy/early pregnancy screening technology, carrier screening has developed from initially targeting specific populations and diseases to targeting the general population and multiple diseases now. It has shown significant clinical efficacy in preventing and controlling birth defects caused by autosomal recessive or X-linked genetic diseases, and has increased the reproductive autonomy of couples undergoing testing. To standardize laboratory testing and clinical implementation of carrier screening, this expert consensus was developed by experts from the Reproductive Health Branch of the Chinese Maternal and Child Health Association, taking into account the actual situation in China, and is provided for clinical reference.
中国妇幼保健协会生育保健分会. 针对生育人群的携带者筛查实验室和临床实践专家共识[J]. 中华生殖与避孕杂志,2024,44(02):109-115.
DOI:10.3760/cma.j.cn101441-20230829-00094版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
黄荷凤负责论文构思、撰写及修改;徐晨明负责论文构思和撰写;陈松长、杨昀负责论文撰写及修改;共识编写专家组其他成员负责论文的修改

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。